There are currently two FDA-approved CAR T cell products for multiple myeloma: Ide-cel and cilta-cel. Ide-cel impressively decreases signs of multiple myeloma in 72% of patients, and cilta-cel 98% ...

To make the V8 that would go on to power the E39, BMW’s engineers took the old M62, increased the displacement, added new ...

In their study, researchers Wang et al. sought to grow a universal source of cytotoxic T cells to use in cell therapies such as CAR T. These cells would be allogeneic, or not derived from the patient.